Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease

Giuseppe Valerio, Pierluigi Bracciale, Anna D’Agostino

Therapeutic Advances in Respiratory Disease

Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study

Felix Herth, Ralf Eberhard, Daniela Gompelmann, +2

Therapeutic Advances in Respiratory Disease

Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal study

Roberto Bernabéu-Mora, Gloria García-Guillamón, Elisa Valera-Novella, +3

Therapeutic Advances in Respiratory Disease

The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease

Justine Briand, Hélène Behal, Cécile Chenivesse, +2

Therapeutic Advances in Respiratory Disease

Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation

Yvonne Goërtz, Martijn A. Spruit, Alex J. van ‘t Hul, +16

Therapeutic Advances in Respiratory Disease

Validation of a visual analog scale for assessing cough severity in patients with chronic cough

Allison Martin Nguyen, Elizabeth D. Bacci, Margaret Vernon, +4

Therapeutic Advances in Respiratory Disease

Value of preoperative 6-minute walk test for predicting postoperative pulmonary complications

Warangkana Keeratichananont, Chokchai Thanadetsuntorn, Suriya Keeratichananont

Therapeutic Advances in Respiratory Disease

Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study

Ken M. Kunisaki, Kathryn Rice, Edward N. Janoff, +2

Therapeutic Advances in Respiratory Disease

Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials

François Maltais, Sally Singh, Alison Donald, +4

Therapeutic Advances in Respiratory Disease

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study

Aikaterini Detoraki, Eugenio Tremante, Maria D’Amato, +9

Therapeutic Advances in Respiratory Disease